Abstract
The genome sequences of some genes have been implicated to carry various mutations that lead to the initiation and advancement of lung cancer. In addition, it has been scientifically established that anytime we breathe out, chemicals called Volatile Organic Compounds (VOCs) are released from the breath. Hundreds of such VOCs have been uniquely identified from samples of breathe collected from lung cancer patients, which make them viable as chemical biomarkers for lung cancer. Based on the foregoing scientific breakthroughs, we developed breathogenomics, a computational architecture for screening, early diagnosis and genoty** of lung cancer victims anchored on the analysis of exhaled breath and mutational profiles of genomic biomarkers. The architecture contains two important sub-modules. At the first sub-module, the exhaled breadths of smokers or persons that are at risk of lung cancer are collected and appropriate computational algorithms are employed to determine the presence of any of the VOC biomarkers. Next, a patient with any VOC biomarker in the exhaled breath proceeds to the second sub-module, which contains appropriate computational models for the detection of mutated genes. Once mutations are detected in any of the biomarker genes found in a given patient, such patient is recommended for targeted therapy to promptly curtail the progression of the mutations to advanced stages. The breathogenomics architecture serves as a generic template for the development of clinical equipment for breath and genomic based screening, early diagnosis and genoty** of lung cancer. In this paper, we report the preliminary result obtained from the prototype that we are currently develo** based on the architecture. Constructing a lung cancer early diagnosis/screening system based on the prototype when fully developed will hopefully minimize the current spate of deaths as a result of late diagnosis of the disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., Smith, H.O., Yandell, M., Evans, C.A., Holt, R.A., Gocayne, J.D.: The sequence of the human genome. Science 291(5507), 1304–1351 (2001)
Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., Funke, R.: Initial sequencing and analysis of the human genome. Nature 409(6822), 860–921 (2001)
Baldwin, D.R., Callister, M.E.: What is the optimum screening strategy for the early detection of lung cancer. Clin. Oncol. 28(11), 672–681 (2016)
Chen, X., Cao, M., Hao, Y., Li, Y., Wang, P., Ying, K., Pan, H.: A non-invasive detection of lung cancer combined virtual gas sensors array with imaging recognition technique. In: 2005 IEEE-EMBS 27th Annual International Conference on Engineering in Medicine and Biology Society, pp. 5873–5876 (2006)
Marshall, H.M., Bowman, R.V., Vang, I.A., Fong, K.M., Berg, C.D.: Screening for lung cancer with low dose computed tomograph: a review of current status. J. Thorac. Dis. 5(Suppl. 5), S524–S539 (2013)
Cornfield, J., Haenszel, W., Hammond, E.C., Lilienfeld, A.M., Shimkin, M.B., Wynder, E.L.: Smoking and lung cancer: recent evidence and a discussion of some questions. Int. J. Epidemiol. 38(5), 1175–1191 (2009)
Michael, P., Kevin, G.: Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 353, 1930–1933 (1999)
Michael, P., Renee, N.C., Andrew, R.C.C., Anthony, J.G., Kevin, G., Joel, G., Roger, A.M., William, N.R.: Detection of lung cancer with volatile markers in the breath. Chest 123, 2115–2123 (2003)
Szulejko, J.E., McCulloch, M., Jackson, J., McKee, D.L., Walker, J.C., Solouki, T.: Evidence for cancer biomarkers in exhaled breath. IEEE Sens. J. 10(1), 185–210 (2010)
Schmekel, B., Winquist, F., Vikström, A.: Analysis of breath samples for lung cancer survival. Anal. Chim. Acta 20(840), 82–86 (2014)
Dragonieri, S., Annema, J.T., Schot, R., Van der Schee, M.P., Spanevello, A., Carratú, P., Resta, O., Rabe, K.F., Sterk, P.J.: An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 64(2), 166–170 (2009)
Adetiba, E., Olugbara, O.O.: Lung cancer prediction using neural network ensemble with histogram of oriented gradient genomic features. Sci. World J. 2015(786013), 1–17 (2015)
Ramani, R.G., Jacob, S.G.: Improved classification of lung cancer tumors based on structural and physicochemical properties of proteins using data mining models. PLoS ONE 8(3), e58772 (2013)
Chen, Y., Shi, J.-X., Pan, X.-F., Feng, J., Zhao, H.: Identification of candidate genes for lung cancer somatic mutation test kits. Genet. Mol. Biol. 36(3), 455–464 (2013)
Marchevsky, A.M., Tsou, J.A., Laird-Offringa, I.A.: Classification of individual lung cancer cell lines based on DNA methylation markers: use of linear discriminant analysis and artificial neural networks. J. Mol. Diagn. 6(1), 28–36 (2004)
Adetiba, E., Olugbara, O.O.: Improved classification of lung cancer using radial basis function neural network with affine transforms of voss representation. PLoS ONE 10(12), e0143542 (2015)
Adiguzel, Y., Kulah, H.: Breathe sensors for lung cancer diagnosis. Biosens. Bioelectron. 65, 121–138 (2015)
Forbes, S.A., Bindal, N., Bamford, S., Cole, C., Kok, C.Y., Beare, D., et al.: COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res. 39, D945–D950 (2010)
Wang, Y., Hill, K., Singh, S., Kari, L.: The spectrum of genomic signatures: from dinucleotides to chaos game representation. Gene 346, 173–178 (2005)
Vijayan, K., Nair, V.V., Gopinath, D.P.: Classification of organisms using frequency-chaos game representation of genomic sequences and ANN. In: 10th National Conference on Technological Trends (NCTT 2009), pp. 6–7 (2009)
Zou, K.H., O’Malley, A.J., Mauri, L.: Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115(5), 654–657 (2007)
Acknowledgement
The publication of this study is supported and funded by the Covenant University Centre for Research, Innovation and Development (CUCRID), Covenant University, Canaanland, Ota, Ogun State, Nigeria.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this paper
Cite this paper
Adetiba, E., Adebiyi, M.O., Thakur, S. (2017). Breathogenomics: A Computational Architecture for Screening, Early Diagnosis and Genoty** of Lung Cancer. In: Rojas, I., Ortuño, F. (eds) Bioinformatics and Biomedical Engineering. IWBBIO 2017. Lecture Notes in Computer Science(), vol 10209. Springer, Cham. https://doi.org/10.1007/978-3-319-56154-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-56154-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56153-0
Online ISBN: 978-3-319-56154-7
eBook Packages: Computer ScienceComputer Science (R0)